Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CMS Energy
CMS
$21.5B
| $3.63M | 0.07% |
57,745
-19,940
| -26% | -$1.24M |
|
327
Jabil
JBL
$32.1B
| $3.6M | 0.07% |
87,226
+20,231
| +30% | +$776K |
|
328
Integer Holdings
ITGR
$4.26B
| $3.59M | 0.07% |
44,685
-37,900
| -46% | -$2.89M |
|
329
Skyworks Solutions
SWKS
$10.1B
| $3.59M | 0.07% |
29,722
+18,194
| +158% | +$1.79M |
|
330
Synaptics
SYNA
$3.68B
| $3.58M | 0.07% |
54,376
+47,845
| +733% | +$2.52M |
|
331
Curtiss-Wright
CW
$22.7B
| $3.56M | 0.07% |
25,276
+23,015
| +1,018% | +$3.12M |
|
332
Sabre
SABR
$900M
| $3.56M | 0.07% |
158,531
+97,295
| +159% | +$2.16M |
|
333
Innospec
IOSP
$2.33B
| $3.54M | 0.06% |
34,192
-1,540
| -4% | -$147K |
|
334
Albany International
AIN
$1.64B
| $3.53M | 0.06% |
46,486
+15,746
| +51% | +$1.31M |
|
|
AYX
335
DELISTED
Alteryx Inc
AYX
| $3.52M | 0.06% |
35,142
-16,424
| -32% | -$1.67M |
|
336
Tyson Foods
TSN
$20.4B
| $3.52M | 0.06% |
38,606
-2,679
| -6% | -$230K |
|
337
Harley-Davidson
HOG
$2.93B
| $3.51M | 0.06% |
94,394
+63,538
| +206% | +$2.37M |
|
338
CDW
CDW
$16.5B
| $3.5M | 0.06% |
24,529
-63,313
| -72% | -$8.38M |
|
339
Omnicell
OMCL
$1.58B
| $3.5M | 0.06% |
42,765
-18,995
| -31% | -$1.46M |
|
|
GAP
340
The Gap Inc
GAP
$7.31B
| $3.46M | 0.06% |
196,007
+171,512
| +700% | +$2.92M |
|
341
Kinder Morgan
KMI
$69B
| $3.46M | 0.06% |
163,427
-653,453
| -80% | -$13.2M |
|
342
Bausch Health
BHC
$2.46B
| $3.44M | 0.06% |
114,815
-83,888
| -42% | -$2.18M |
|
343
CONMED
CNMD
$1.55B
| $3.43M | 0.06% |
+30,687
| New | +$3.27M |
|
344
General Dynamics
GD
$103B
| $3.43M | 0.06% |
19,443
+18,334
| +1,653% | +$3.29M |
|
345
Invesco
IVZ
$14.3B
| $3.43M | 0.06% |
190,711
-17,103
| -8% | -$292K |
|
346
Sempra
SRE
$55.1B
| $3.43M | 0.06% |
45,262
-246,608
| -84% | -$18.1M |
|
347
J.M. Smucker
SJM
$13.4B
| $3.41M | 0.06% |
32,784
-15,106
| -32% | -$1.6M |
|
348
West Pharmaceutical
WST
$24.7B
| $3.37M | 0.06% |
22,401
+13,860
| +162% | +$2.02M |
|
349
Polaris
PII
$3.65B
| $3.35M | 0.06% |
32,990
+17,156
| +108% | +$1.66M |
|
350
Open Text
OTEX
$5.97B
| $3.35M | 0.06% |
76,108
-68,824
| -47% | -$2.89M |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.